Tactile Systems Technology (TCMD) Competitors

$26.45 +0.23 (+0.88%)

As of 06/23/2026 04:00 PM Eastern

TCMD vs. AXGN, LMAT, NVCR, PLSE, and BFLY

Should you buy Tactile Systems Technology stock or one of its competitors? MarketBeat compares Tactile Systems Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tactile Systems Technology include AxoGen (AXGN), LeMaitre Vascular (LMAT), NovoCure (NVCR), Pulse Biosciences (PLSE), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.

How does Tactile Systems Technology compare to AxoGen?

AxoGen (NASDAQ:AXGN) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

Tactile Systems Technology has a net margin of 5.91% compared to AxoGen's net margin of -13.21%. Tactile Systems Technology's return on equity of 9.70% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-13.21%	-9.63%	-6.26%
Tactile Systems Technology	5.91%	9.70%	7.53%

Tactile Systems Technology has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$225.21M	10.55	-$15.70M	-$0.64	N/A
Tactile Systems Technology	$329.52M	1.81	$19.09M	$0.88	30.06

80.3% of AxoGen shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 2.4% of AxoGen shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, AxoGen had 3 more articles in the media than Tactile Systems Technology. MarketBeat recorded 3 mentions for AxoGen and 0 mentions for Tactile Systems Technology. AxoGen's average media sentiment score of 1.61 beat Tactile Systems Technology's score of 0.00 indicating that AxoGen is being referred to more favorably in the media.

Company	Overall Sentiment
AxoGen	Very Positive
Tactile Systems Technology	Neutral

AxoGen currently has a consensus price target of $46.50, indicating a potential upside of 4.05%. Tactile Systems Technology has a consensus price target of $38.60, indicating a potential upside of 45.94%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, analysts plainly believe Tactile Systems Technology is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

AxoGen has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Summary

Tactile Systems Technology beats AxoGen on 11 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

LeMaitre Vascular has a net margin of 24.35% compared to Tactile Systems Technology's net margin of 5.91%. LeMaitre Vascular's return on equity of 15.36% beat Tactile Systems Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	24.35%	15.36%	9.78%
Tactile Systems Technology	5.91%	9.70%	7.53%

84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

LeMaitre Vascular has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

LeMaitre Vascular currently has a consensus price target of $112.60, suggesting a potential upside of 22.46%. Tactile Systems Technology has a consensus price target of $38.60, suggesting a potential upside of 45.94%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, analysts plainly believe Tactile Systems Technology is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.75
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

LeMaitre Vascular has higher earnings, but lower revenue than Tactile Systems Technology. Tactile Systems Technology is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	8.42	$57.73M	$2.71	33.93
Tactile Systems Technology	$329.52M	1.81	$19.09M	$0.88	30.06

In the previous week, LeMaitre Vascular had 3 more articles in the media than Tactile Systems Technology. MarketBeat recorded 3 mentions for LeMaitre Vascular and 0 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.00 beat LeMaitre Vascular's score of -0.12 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
LeMaitre Vascular	Neutral
Tactile Systems Technology	Neutral

Summary

LeMaitre Vascular beats Tactile Systems Technology on 10 of the 15 factors compared between the two stocks.

How does Tactile Systems Technology compare to NovoCure?

Tactile Systems Technology (NASDAQ:TCMD) and NovoCure (NASDAQ:NVCR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Tactile Systems Technology has higher earnings, but lower revenue than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.81	$19.09M	$0.88	30.06
NovoCure	$655.35M	2.50	-$136.23M	-$1.53	N/A

Tactile Systems Technology has a net margin of 5.91% compared to NovoCure's net margin of -25.66%. Tactile Systems Technology's return on equity of 9.70% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
NovoCure	-25.66%	-50.82%	-16.48%

Tactile Systems Technology has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, NovoCure has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

Tactile Systems Technology presently has a consensus price target of $38.60, suggesting a potential upside of 45.94%. NovoCure has a consensus price target of $26.86, suggesting a potential upside of 90.07%. Given NovoCure's higher possible upside, analysts clearly believe NovoCure is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
NovoCure	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 84.6% of NovoCure shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by insiders. Comparatively, 5.5% of NovoCure shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, NovoCure had 19 more articles in the media than Tactile Systems Technology. MarketBeat recorded 19 mentions for NovoCure and 0 mentions for Tactile Systems Technology. NovoCure's average media sentiment score of 0.01 beat Tactile Systems Technology's score of 0.00 indicating that NovoCure is being referred to more favorably in the news media.

Company	Overall Sentiment
Tactile Systems Technology	Neutral
NovoCure	Neutral

Summary

Tactile Systems Technology and NovoCure tied by winning 8 of the 16 factors compared between the two stocks.

How does Tactile Systems Technology compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

In the previous week, Pulse Biosciences' average media sentiment score of 0.00 equaled Tactile Systems Technology'saverage media sentiment score.

Company	Overall Sentiment
Pulse Biosciences	Neutral
Tactile Systems Technology	Neutral

77.0% of Pulse Biosciences shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 74.0% of Pulse Biosciences shares are owned by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Tactile Systems Technology has a net margin of 5.91% compared to Pulse Biosciences' net margin of 0.00%. Tactile Systems Technology's return on equity of 9.70% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	N/A	-86.67%	-73.61%
Tactile Systems Technology	5.91%	9.70%	7.53%

Pulse Biosciences has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

Pulse Biosciences presently has a consensus target price of $30.67, indicating a potential upside of 18.18%. Tactile Systems Technology has a consensus target price of $38.60, indicating a potential upside of 45.94%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, analysts plainly believe Tactile Systems Technology is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

Tactile Systems Technology has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$350K	5,131.43	-$72.78M	-$1.10	N/A
Tactile Systems Technology	$329.52M	1.81	$19.09M	$0.88	30.06

Summary

Tactile Systems Technology beats Pulse Biosciences on 12 of the 15 factors compared between the two stocks.

How does Tactile Systems Technology compare to Butterfly Network?

Tactile Systems Technology (NASDAQ:TCMD) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Tactile Systems Technology has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.81	$19.09M	$0.88	30.06
Butterfly Network	$102.92M	19.03	-$77.06M	-$0.30	N/A

In the previous week, Butterfly Network had 10 more articles in the media than Tactile Systems Technology. MarketBeat recorded 10 mentions for Butterfly Network and 0 mentions for Tactile Systems Technology. Butterfly Network's average media sentiment score of 0.36 beat Tactile Systems Technology's score of 0.00 indicating that Butterfly Network is being referred to more favorably in the news media.

Company	Overall Sentiment
Tactile Systems Technology	Neutral
Butterfly Network	Neutral

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 37.8% of Butterfly Network shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by company insiders. Comparatively, 22.0% of Butterfly Network shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Tactile Systems Technology currently has a consensus target price of $38.60, suggesting a potential upside of 45.94%. Butterfly Network has a consensus target price of $5.56, suggesting a potential downside of 27.67%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, analysts plainly believe Tactile Systems Technology is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
Butterfly Network	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Tactile Systems Technology has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Butterfly Network has a beta of 2.22, meaning that its share price is 122% more volatile than the broader market.

Tactile Systems Technology has a net margin of 5.91% compared to Butterfly Network's net margin of -73.63%. Tactile Systems Technology's return on equity of 9.70% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
Butterfly Network	-73.63%	-34.41%	-23.91%

Summary

Tactile Systems Technology beats Butterfly Network on 12 of the 17 factors compared between the two stocks.

Get Tactile Systems Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TCMD vs. The Competition

Export

Metric	Tactile Systems Technology	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$591.42M	$7.05B	$6.44B	$12.38B
Dividend Yield	N/A	1.27%	2.69%	5.83%
P/E Ratio	30.06	48.65	24.66	23.99
Price / Sales	1.81	76.50	528.55	106.76
Price / Cash	22.76	24.78	44.82	54.51
Price / Book	2.70	7.13	10.83	6.50
Net Income	$19.09M	$159.20M	$3.56B	$336.88M
7 Day Performance	2.40%	-1.92%	0.93%	-0.16%
1 Month Performance	6.22%	-2.88%	0.36%	0.76%
1 Year Performance	155.06%	4.79%	29.66%	28.49%

Tactile Systems Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TCMD Tactile Systems Technology	3.2432 of 5 stars	$26.45 +0.9%	$38.60 +45.9%	+160.1%	$591.42M	$329.52M	30.06	1,086
AXGN AxoGen	1.9486 of 5 stars	$43.90 +0.4%	$46.50 +5.9%	+356.5%	$2.34B	$225.21M	N/A	450	Positive News
LMAT LeMaitre Vascular	4.6299 of 5 stars	$93.33 +1.5%	$112.60 +20.6%	+10.3%	$2.13B	$249.60M	34.35	490
NVCR NovoCure	3.0373 of 5 stars	$17.75 +0.8%	$27.29 +53.8%	-14.9%	$2.05B	$655.35M	N/A	1,605	Analyst Revision
PLSE Pulse Biosciences	1.9394 of 5 stars	$25.16 -3.0%	$30.67 +21.9%	+67.5%	$1.74B	$350K	N/A	140

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TCMD) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tactile Systems Technology (TCMD) Competitors

TCMD vs. AXGN, LMAT, NVCR, PLSE, and BFLY

How does Tactile Systems Technology compare to AxoGen?

Summary

How does Tactile Systems Technology compare to LeMaitre Vascular?

Summary

How does Tactile Systems Technology compare to NovoCure?

Summary

How does Tactile Systems Technology compare to Pulse Biosciences?

Summary

How does Tactile Systems Technology compare to Butterfly Network?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD vs. The Competition

Tactile Systems Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tactile Systems Technology (TCMD) Competitors

TCMD vs. AXGN, LMAT, NVCR, PLSE, and BFLY

How does Tactile Systems Technology compare to AxoGen?

Is AXGN or TCMD more profitable?

Which has higher earnings & valuation, AXGN or TCMD?

Do institutionals and insiders believe in AXGN or TCMD?

Does the media refer more to AXGN or TCMD?

Do analysts prefer AXGN or TCMD?

Which has more risk & volatility, AXGN or TCMD?

Summary

How does Tactile Systems Technology compare to LeMaitre Vascular?

Is LMAT or TCMD more profitable?

Do institutionals and insiders have more ownership in LMAT or TCMD?

Which has more volatility and risk, LMAT or TCMD?

Do analysts recommend LMAT or TCMD?

Which has stronger earnings and valuation, LMAT or TCMD?

Does the media refer more to LMAT or TCMD?

Summary

How does Tactile Systems Technology compare to NovoCure?

Which has preferable valuation & earnings, TCMD or NVCR?

Is TCMD or NVCR more profitable?

Which has more risk & volatility, TCMD or NVCR?

Do analysts prefer TCMD or NVCR?

Do insiders & institutionals hold more shares of TCMD or NVCR?

Does the media prefer TCMD or NVCR?

Summary

How does Tactile Systems Technology compare to Pulse Biosciences?

Does the media refer more to PLSE or TCMD?

Do insiders and institutionals hold more shares of PLSE or TCMD?

Is PLSE or TCMD more profitable?

Which has more risk and volatility, PLSE or TCMD?

Do analysts prefer PLSE or TCMD?

Which has higher valuation & earnings, PLSE or TCMD?

Summary

How does Tactile Systems Technology compare to Butterfly Network?

Which has better earnings and valuation, TCMD or BFLY?

Does the media prefer TCMD or BFLY?

Do institutionals and insiders hold more shares of TCMD or BFLY?

Do analysts recommend TCMD or BFLY?

Which has more volatility and risk, TCMD or BFLY?

Is TCMD or BFLY more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD vs. The Competition

Tactile Systems Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools